Search clinical trials for: YHD1023
Total 1 results
-
Yuhan CorporationCompleted
Sponsors and Collaborators
- Semyung University Affiliated Oriental Medical Hospital
- Riverview Health Centre Foundation
- Beijing Municipal Education Commission
- Health Pharma Professional Research
- Oblikue Consulting
- Ayse Cal
- Neijiang Center for Disease Control and Prevention
- Semler Scientific
- Prof. OTTO Beisheim Stiftung (Germany)
- Andre Tsin Chih Chen
- The Third Hospital of HanDan
- The Finnish Hearth Association
- CP-foreningen
- Hyben Vital ApS
- PETROSYAN Andreanik
- Antonio Martín Duce
- ICE Intelligent Healthcare Co., Ltd
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Livivos, Inc.
- Notitia Biotechnologies Company
- View Full List
Medical Conditions
- Refractory Oropharyngeal Squamous Cell Carcinoma
- Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)
- Peritoneal Dialysis-related Infection
- Male Patients
- Weight Loss Trajectory
- TGF-β
- Medication Induced Acute Pancreatitis
- Sprain of Sacroiliac Ligament
- Acute T Lymphoblastic Leukemia (T-ALL)
- Non-Melanomatous Skin Cancer
- Systemic Nickel Allergic Syndrome
- Adult T Lymphoblastic Lymphoma
- Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- Visual Field Defect Homonymous Bilateral
- Muscle Stretching Exercise; Postural Balance; Stabilometry; Platform
- Chronic Heart Disease
- The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase
- GI Bleed
- Invasive Group A Streptococcal Disease
- Under-eyes Dark Circles
- View Full List
Drug Interventions
- Crushed d-amphetamine sulfate IR tablets
- DTG/3TC
- Aclidinium bromide
- Low Intensity Counseling + bupropion + PRN NRT
- Anlotinib
- Naproxen
- MEDI4736
- Quarfloxin
- Glimepiride
- Irinotecan
- Triamcinolone
- AL-53817 Ophthalmic Solution, 0.1%
- Anti-Rejection Agents
- Ketorolac
- Vaway
- Empagliflozin 25 mg
- Venetoclax
- Lisinopril and Hydrochlorothiazide Tablets (20+25) mg
- Durvalumab and Tremelimumab
- Fluoxetine
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Estonia
- Contract Research Organizations in Germany
- Contract Research Organizations in Ghana
- Contract Research Organizations in India
- Contract Research Organizations in Israel
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Portugal
- Contract Research Organizations in Qatar
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Zimbabwe
- CRO list by country